Search Results - "Meraz IM"

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.

Authors: Meraz IM Majidi M Fang B et al.

Source: Communications biology [Commun Biol] 2023 Jun 06; Vol. 6 (1), pp. 608. Date of Electronic Publication: 2023 Jun 06.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE; PubMed not MEDLINE

Correction: Multivalent Presentation of MPL by Porous Silicon Microparticles Favors T Helper 1 Polarization Enhancing the Anti-Tumor Efficacy of Doxorubicin Nanoliposomes.

Authors: Meraz, Ismail M. Hearnden, Claire H. Liu, Xuewu et al.

Source: PLoS ONE. 11/21/2024, Vol. 19 Issue 11, p1-3. 3p.

Distinct molecular subtypes of KRAS^G12C‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies.

Authors: Yang, Haitang Zhu, Anshun Niu, Yongliang et al.

Source: Clinical & Translational Medicine. Oct2025, Vol. 15 Issue 10, p1-27. 27p.

Navigating toxicity in lung cancer immunotherapy: challenges and advances in Nano medicine drug delivery.

Authors: Jain R Chettupalli AK Bukke SPN et al.

Source: Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2026 Jun 29; Vol. 38 (1). Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: SpringerOpen Country of Publication: England NLM ID: 9424566 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0409 (Electronic) Linking ISSN: 11100362 NLM ISO Abbreviation: J Egypt Natl Canc Inst Subsets: MEDLINE

The application of experimental models for the drug discovery for digestive tumors.

Authors: Zheng L Shuai W Liu Y et al.

Source: Molecular cancer [Mol Cancer] 2026 Feb 23; Vol. 25 (1). Date of Electronic Publication: 2026 Feb 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

SMARCA4-deficient non-small cell lung cancer and immunotherapy resistance: mechanisms and novel strategies-a mini-review.

Authors: Lin X Ji Y Lin B et al.

Source: Discover oncology [Discov Oncol] 2026 Mar 03; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Dynamic changes in immune cells in humanized liver metastasis and subcutaneous xenograft mouse models.

Authors: Bang, Hyun Jin Lee, Kyung-Hwa Park, Myong Suk et al.

Source: Scientific Reports. 9/2/2024, Vol. 14 Issue 1, p1-13. 13p.

Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions.

Authors: Mandal, Kartik Barik, Ganesh Kumar Santra, Manas Kumar

Source: Molecular Cancer. 10/8/2025, Vol. 24 Issue 1, p1-52. 52p.

Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer.

Authors: Bharadwaj, Shiv Mierzwicka, Joanna Maria Vaňková, Lucie et al.

Source: Cell Communication & Signaling. 9/29/2025, Vol. 23 Issue 1, p1-62. 62p.

Fetal liver CD34⁺ contain human immune and endothelial progenitors and mediate solid tumor rejection in NOG mice.

Authors: Celhar, Teja Li, Xinyi Zhao, Yunqian et al.

Source: Stem Cell Research & Therapy. 6/9/2024, Vol. 15 Issue 1, p1-19. 19p.

Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.

Authors: Jain A Rosell R Dharmashekara C et al.

Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE

Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?

Authors: Fu, Shenao Ma, Jiayao Cai, Changjing et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 7/3/2025, Vol. 44 Issue 1, p1-31. 31p.

Small intestinal SMARCA4-deficient undifferentiated carcinoma with intussusception: A case report.

Authors: Cai, Xiaoshan Liu, Shanshan Li, Linqian et al.

Source: Oncology Letters. Feb2026, Vol. 31 Issue 2, pN.PAG-N.PAG. 1p.

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.

Authors: Meraz, Ismail M. Majidi, Mourad Fang, Bingliang et al.

Source: Communications Biology. 6/7/2023, Vol. 6 Issue 1, p1-17. 17p.

Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy.

Authors: Liu, Naimeng Wang, Xiangyu Wang, Zhongzhao et al.

Source: Journal of Hematology & Oncology. 4/17/2025, Vol. 18 Issue 1, p1-30. 30p.

The Fas-FasL system: from apoptosis regulator to therapeutic target in autoimmunity, cancer, and transplantation.

Authors: Gadelkarim M Elsayed A Nazir A et al.

Source: Immunologic research [Immunol Res] 2026 Mar 16; Vol. 74 (1). Date of Electronic Publication: 2026 Mar 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8611087 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0755 (Electronic) Linking ISSN: 0257277X NLM ISO Abbreviation: Immunol Res Subsets: MEDLINE

Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma.

Authors: Stephan SB Cummings CL Fitzgerald K et al.

Source: Gene therapy [Gene Ther] 2026 Mar; Vol. 33 (2), pp. 118-126. Date of Electronic Publication: 2026 Feb 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE

Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies.

Authors: Khan, Sam Miles, Gareth J Demetriou, Constantinos et al.

Source: Mutagenesis. Sep-Nov2022, Vol. 37 Issue 5/6, p227-237. 11p.

New insights into allergic rhinitis treatment: MSC nanovesicles targeting dendritic cells.

Authors: Liu, Jianyu Wang, Meiqun Tian, Xiaoyan et al.

Source: Journal of Nanobiotechnology. 9/18/2024, Vol. 22 Issue 1, p1-33. 33p.

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells.

Authors: Hou, Xiaoying Du, Cong Lu, Ligong et al.

Source: World Journal of Surgical Oncology. 2/17/2022, Vol. 20 Issue 1, p1-9. 9p.